Here’s why you’re not excited enough about Pfizer’s COVID vaccine

Monday morning brought the sweet, sweet news that Pfizer’s RNA-based COVID-19 vaccine has turned out to be extremely effective in its Phase 3 trial. While the news itself has been all over social media and has resulted in an instant 5% jump in the stock market, much of the press coverage has actually been not

Even if a COVID-19 vaccine were approved tomorrow, “normal” is still a long way off

For months now, Americans have waited anxiously for the first wave of coronavirus vaccines to be approved in the US. Most of us are watching the FDA’s vaccine approval timeline because we take that approval to be the critical first step in answering the number one question on everyone’s mind: when will life get back